التفاصيل البيبلوغرافية
| العنوان: |
The role of neoantigens in response to immune checkpoint blockade. |
| المؤلفون: |
Riaz, Nadeem, Morris, Luc, Havel, Jonathan J., Makarov, Vladimir, Desrichard, Alexis, Chan, Timothy A. |
| المصدر: |
International Immunology; Aug2016, Vol. 28 Issue 8, p411-419, 9p |
| مصطلحات موضوعية: |
CANCER patients, CANCER treatment, IMMUNE system, PROGRAMMED cell death 1 receptors, CYTOTOXIC T lymphocyte-associated molecule-4 |
| مستخلص: |
Immune checkpoint blockade has demonstrated substantial promise for the treatment of several advanced malignancies. These agents activate the immune system to attack tumor cells. For example, agents targeting CTLA4 and programmed cell death 1 (PD-1) have resulted in impressive response rates and, in some cases, durable remissions. Neoantigens are mutations that encode immunologically active proteins that can cause the immune system to recognize the affected cell as foreign. Recent data have made it clear that these mutations are, in large part, the functional targets of immune checkpoint blockade. This review summarizes the key discoveries leading up to this important conclusion and discusses possible applications of neoantigens in cancer therapy. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Immunology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder